- Author(s):
- Organization(s):
Pearl Therapeutics, Inc. (an AstraZeneca Company)
A review of recent advances and characterization techniques to support respiratory product development.
A variety of techniques are reviewed for use in solid phase identification and quantification; particle morphology imaging and particle density estimations; surface property and interparticle interaction investigations; and predicting thermal activity and long-term physical and chemical stability.